These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 35534402)

  • 1. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
    Dunphy L; Boyle S; Wood F
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
    Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
    Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.
    Jespersen C; Lauritsen MP; Frokjaer VG; Schroll JB
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD001396. PubMed ID: 39140320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.
    Frackiewicz EJ; Shiovitz TM
    J Am Pharm Assoc (Wash); 2001; 41(3):437-47. PubMed ID: 11372908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca].
    McHichi alami Kh; Tahiri SM; Moussaoui D; Kadri N
    Encephale; 2002; 28(6 Pt 1):525-30. PubMed ID: 12506265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.
    Rapkin AJ; Mikacich JA
    Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].
    Haußmann J; Goeckenjan M; Haußmann R; Wimberger P
    Nervenarzt; 2024 Mar; 95(3):268-274. PubMed ID: 38393358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture and acupressure for premenstrual syndrome.
    Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMS and PMDD in the domain of mental health nursing.
    Stearns S
    J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):16-27. PubMed ID: 11197992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual dysphoric disorder. A guide for the treating clinician.
    Elliott H
    N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Brown J; O' Brien PM; Marjoribanks J; Wyatt K
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001396. PubMed ID: 19370564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.